SCHEMBL29640916

SCHEMBL29640916

O=c1ccnc(-c2ccncn2)n1-c1ccccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
GSK3B P49841 2/20 0.40
CYP2D6 P10635 1/20 0.40
EP300 Q09472 1/20 0.39
KAT2B Q92831 1/20 0.39
HTT P42858 1/20 0.36
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
ALOX5 P09917 1/20 0.35
TNKS O95271 1/20 0.35
TNKS2 Q9H2K2 1/20 0.35
ALDH1A1 P00352 3/20 0.35
NOX4 Q9NPH5 1/20 0.34
NOX1 Q9Y5S8 1/20 0.34
KDM4E B2RXH2 3/20 0.33
GAA P10253 2/20 0.33
DPP4 P27487 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29640776 0.72 GSK3B (0.37) GSK3B
SCHEMBL29640865 0.70 GSK3B (0.36) GSK3BCYP2D6
SCHEMBL4294864 0.66 KDM4E (0.67) SMN1; SMN2HTTALDH1A1KDM4EHPGD
SCHEMBL28379997 0.66 SMN1; SMN2 (0.55) SMN1; SMN2GSK3BEP300KAT2BHTT
SCHEMBL29394083 0.66 KDM4E (0.67) SMN1; SMN2HTTALDH1A1KDM4EHPGD
SCHEMBL29241760 0.64 EP300 (0.46) SMN1; SMN2GSK3BEP300KAT2BPDCD1
SCHEMBL28683528 0.64 SMN1; SMN2 (0.49) SMN1; SMN2EP300KAT2BHTTPDCD1
SCHEMBL12661008 0.63 EP300 (0.53) SMN1; SMN2GSK3BEP300KAT2BHTT
SCHEMBL7102988 0.63 KAT2B (0.46) SMN1; SMN2EP300KAT2BHTTPDCD1
SCHEMBL27862934 0.62 HSD17B10 (0.49) SMN1; SMN2HTTALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114502163-A Ethynylheterocycles as RHO-related coiled coil kinase (ROCK) inhibitors 安吉昂生物医药公司 2022-05-13 CN disclosed